Induced pluripotent stem cell technology in bone biology

被引：5
|
作者：
Kidwai, Fahad K. [1 ,3 ]
Canalis, Ernesto [2 ]
Robey, Pamela G. [1 ]
机构：
[1] Natl Inst Dent & Craniofacial Res, Skeletal Biol Sect, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[2] UConn Hlth, UConn Musculoskeletal Inst, Ctr Skeletal Res Orthoped Surg & Med, Farmington, CT 06030 USA
[3] Natl Inst Child Hlth Dev, Sect Mol & Therapies Craniofacial & Dent Disorders, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
来源：
BONE | 2023年 / 172卷
基金：
美国国家卫生研究院;
关键词：
Pluripotent stem cells; Induced pluripotent stem cells R; Reprogramming; Osteogenic differentiation; Models of disease; NEURAL CREST DEVELOPMENT; HAJDU-CHENEY-SYNDROME; IN-VITRO; ALAGILLE-SYNDROME; MOUSE MODEL; DIRECTED DIFFERENTIATION; NOTCH; EXPRESSION; MESODERM; GENE;
D O I：
10.1016/j.bone.2023.116760
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Technologies on the development and differentiation of human induced pluripotent stem cells (hiPSCs) are rapidly improving, and have been applied to create cell types relevant to the bone field. Differentiation protocols to form bona fide bone-forming cells from iPSCs are available, and can be used to probe details of differentiation and function in depth. When applied to iPSCs bearing disease-causing mutations, the pathogenetic mechanisms of diseases of the skeleton can be elucidated, along with the development of novel therapeutics. These cells can also be used for development of cell therapies for cell and tissue replacement.
引用
收藏
页数：13
相关论文
共 50 条
  • [1] Induced Pluripotent Stem Cell Technology in Regenerative Medicine and Biology
    Pei, Duanqing
    Xu, Jianyong
    Zhuang, Qiang
    Tse, Hung-Fat
    Esteban, Miguel A.
    BIOREACTOR SYSTEMS FOR TISSUE ENGINEERING II: STRATEGIES FOR THE EXPANISON AND DIRECTED DIFFERENTIATION OF STEM CELLS, 2010, 123 : 127 - 141
  • [2] Induced Pluripotent Stem Cell Technology
    Kang, Ke Won
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2010, 7 (03) : 263 - 268
  • [3] Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics
    Maali, Amirhosein
    Maroufi, Faezeh
    Sadeghi, Farzin
    Atashi, Amir
    Kouchaki, Reza
    Moghadami, Mona
    Azad, Mehdi
    EPIGENOMICS, 2021, 13 (08) : 631 - 647
  • [4] Evolution of induced pluripotent stem cell technology
    Zhou, Hongyan
    Ding, Sheng
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (04) : 276 - 280
  • [5] Induced pluripotent stem cells and senescence: learning the biology to improve the technology
    Banito, Ana
    Gil, Jesus
    EMBO REPORTS, 2010, 11 (05) : 353 - 359
  • [6] Induced pluripotent stem cell technology: a decade of progress
    Yanhong Shi
    Haruhisa Inoue
    Joseph C. Wu
    Shinya Yamanaka
    Nature Reviews Drug Discovery, 2017, 16 : 115 - 130
  • [7] Induced pluripotent stem cell technology: a decade of progress
    Shi, Yanhong
    Inoue, Haruhisa
    Wu, Joseph C.
    Yamanaka, Shinya
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) : 115 - 130
  • [8] Induced pluripotent stem cell technology for generating photoreceptors
    Boucherie, Cedric
    Sowden, Jane C.
    Ali, Robin R.
    REGENERATIVE MEDICINE, 2011, 6 (04) : 469 - 479
  • [9] Induced pluripotent stem cell technology and stem cell therapy for diabetes (Review)
    Drummond, Robert J.
    Kunath, Tilo
    Mee, P. Joseph
    Ross, James A.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (01) : 3 - 7
  • [10] Prospects of Induced Pluripotent Stem Cell Technology in Regenerative Medicine
    Zhang, Feng
    Citra, Fudiman
    Wang, Dong-An
    TISSUE ENGINEERING PART B-REVIEWS, 2011, 17 (02) : 115 - 124
12345